Guselkumab maintenance treatment improves health-related quality of life in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR maintenance study

被引：0

作者：

Bressler, B. ^{[1
]}

Peyrin-Biroulet, L. ^{[2
,3
]}

Afif, W. ^{[4
]}

Samaan, M. A. ^{[5
]}

Wei, S. C. ^{[6
]}

Yarandi, S. ^{[7
]}

Germinaro, M.

Mistry, P. ^{[8
]}

Han, C. ^{[9
]}

Allegretti, J. R. ^{[10
]}

Lichtenstein, G. R. ^{[11
]}

机构：

[1] Univ British Columbia, Gastroenterol, Vancouver, BC, Canada

[2] Univ Lorraine, Inserm, NGERE, F-54000 Nancy, France

[3] Grp Hosp Prive Ambroise Pare Hartmann Paris IBD Ct, Gastroenterol, Nancy, France

[4] McGill Univ Hlth Care, Div Gastroenterol, Montreal, PQ, Canada

[5] Guys & St Thomas NHS Fdn Trust, Inflammatory Bowel Dis Unit, London, England

[6] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan

[7] Janssen Res & Dev LLC, Immunol, Spring House, PA USA

[8] Janssen Res & Dev LLC, Biostat, Spring House, PA USA

[9] Janssen Res & Dev LLC, Patient Reported Outcomes, Spring House, PA USA

[10] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA

[11] Univ Penn, Gastroenterol, Philadelphia, PA USA

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.1343

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P1169

引用

页码：i2133 / i2135

页数：3

共 50 条

[1] Guselkumab Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the QUASAR Phase 3 Induction Study
Bressler, Brian
Feagan, Brian G.
Panes, Julian
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Pandya, Dwiti
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Lateef, Syed
Petroniene, Rima
Rayyan, Yaser
Peyrin-Biroulet, Laurent
Rubin, David T.
Hisamatsu, Tadakazu
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S807 - S808
[2] Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
Panes, Julian
Loftus, Edward, V
Higgins, Peter D. R.
Lindsay, James O.
Zhou, Wen
Yao, Xuan
Ilo, Dapo
Phillips, Charles
Tran, Jacinda
Sanchez Gonzalez, Yuri
Vermeire, Severine
INFLAMMATORY BOWEL DISEASES, 2023, : 1421 - 1430
[3] GUSELKUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AS MEASURED BY PROMIS-29 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY
Panes, Julian
Dignass, Axel
Lichtenstein, Gary R.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Houck, Nicole
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Abu Farsakh, Niazy A.
Patel, Bhaktasharan
Owczarek, Danuta
Hisamatsu, Tadakazu
Sands, Bruce E.
Bressler, Brian
GASTROENTEROLOGY, 2024, 166 (05) : S848 - S848
[4] Guselkumab improves health-related quality of life as measured by PROMIS-29 in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study
Panes, J.
Dignass, A.
Lichtenstein, G.
Huang, K. H.
Germinaro, M.
Houck, N.
Han, C.
Miao, Y.
Zhang, H.
Abu Farsakh, N.
Patel, B.
Owczarek, D.
Hisamatsu, T.
Sands, B.
Bressler, B.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I160 - I161
[5] THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY
Rubin, David T.
Allegretti, Jessica R.
Panes, Julian
Shipitofsky, Nicole
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Wilson, Rebbecca
Zhang, Hongyan
Feagan, Brian G.
Hisamatsu, Tadakazu
Lichtenstein, Gary R.
Bressler, Brian
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Dignass, Axel
GASTROENTEROLOGY, 2024, 166 (05) : S180 - S180
[6] The Efficacy of Maintenance Treatment with Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results at Week 44 by Biologic/Janus Kinase History
Allegretti, Jessica R.
Panes, Julian
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Zhan, Jia
Zhang, Hongyan
Begun, Jakob
Kierkus, Jaroslaw
Kravchenko, Tetiana
Hisamatsu, Tadakazu
Rubin, David T.
Bressler, Brian
Dignass, Axel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S882 - S882
[7] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Panes, J.
Rubin, D. T.
Vermeire, S.
Lindsay, J. O.
Sands, B. E.
Su, C.
Friedman, G.
Zhang, H.
Kayhan, C.
Manuchehri, A.
Healey, P.
GUT, 2017, 66 : A121 - A122
[8] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Panes, Julian
Rubin, David T.
Vermeire, Severine
Lindsay, James O.
Sands, Bruce E.
Su, Chinyu
Friedman, Gary
Zhang, Haiying
Kayhan, Cem
Manuchehri, Alireza
Healey, Paul J.
GASTROENTEROLOGY, 2017, 152 (05) : S601 - S602
[9] Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis
Panes, J.
Rubin, D. T.
Vermeire, S.
Lindsay, J. O.
Sands, B. E.
JOURNAL OF CROHNS & COLITIS, 2017, 11 : S315 - S317
[10] Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from, 52-week phase, 3 study U ACHIEVE maintenance
Panes, J.
Loftus, E. V. J.
Higgins, P.
Lindsay, O.
Zhou, W.
Yao, X.
Ilo, D.
Phillips, C.
Tran, J.
Gonzalez, Y. Sanchez
Vermeire, S.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I373 - I374

← 1 2 3 4 5 →